During the past decade, Fortis Hospital Bangalore conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fortis Hospital Bangalore" #1 sponsor was "Bayer" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Allergan" with 1 trials sponsored, "DyAnsys, Inc." with 1 trials sponsored and "Population Health Research Institute" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fortis Hospital Bangalore" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Janssen Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Fortis Hospital Bangalore" are "Endstage Renal Disease" (1 trials), "Heart Failure" (1 trials), "Labor Pain" (1 trials), "Non-metastatic Castration-resistant Prostate Cancer" (1 trials) and "Non-valvular Atrial Fibrillation (NVAF)" (1 trials). Many other conditions were trialed in "Fortis Hospital Bangalore" in a lesser frequency.

Most popular intervention types in "Fortis Hospital Bangalore" are "Drug" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ANSiStim" (1 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "MPP" (1 trials), "Placebo Oral Tablet" (1 trials) and "Rivaroxaban (Xarelto,Bay 59-7939)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fortis Hospital Bangalore" are 4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fortis Hospital Bangalore". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fortis Hospital Bangalore, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fortis Hospital Bangalore, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".